Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3974_Библиотеки_им_академика_М_И_Перельмана
.pdf
187
Index
photodynamic therapy , 168–169
treatment options , 160–161
Prostate cancer (PCa). See Prostate ablation
Pyeloperfusion technique , 141, 142, 146
R
Radiofrequency ablation (RFA)
adrenal ablation , 150–152, 156
AngioDynamics’ StarBurst
®
, 9–10
Boston Scienti fi c , 7–8
breast ablation
in breast cancer , 83
clinical trials , 76–77
in fi broadenoma , 83
procedure , 82
Covidien Cool-Tip , 8–9
de fi nition , 5
electrodes , 6–7
generators , 7
hepatocellular carcinoma , 119, 121–122,
124–125
principles , 5–6
renal ablation
exophytic and parenchymal tumors , 140
sedation/anesthesia , 141
soft tissue tumors , 179–180
thoracic ablation
local recurrence , 107, 112
lung anesthesia , 101
thyroid and parathyroid nodules
aberrant anatomy , 57–58
absolute contraindications , 55
clinical features , 53
complications , 68–69
diagnostic evaluation , 54–55
equipment , 58
ethanol ablation (EA) , 66–67
follow-up and postprocedure
medications , 63–65
high-intensity focused ultrasound
(HIFU) , 67
indications , 55
moving shot technique , 60–62
normal anatomy , 56–57
patient preparation , 56
percutaneous laser ablation (PLA) , 67
postprocedure care , 62–63
preprocedure medications , 59
relative contraindications , 56
results , 65–66
Renal ablation
clinical features/diagnostic evaluation ,
139–140
complications , 145
contraindications , 140
incidence of , 139
indications , 140
partial nephrectomy , 145
patient preparation , 140–141
procedure
biopsy , 141–142
endpoint , 142–143
follow up , 144–145
image guidance , 141
meta-analysis , 145
postprocedure care , 143
sedation/anesthesia , 141
technique , 142
recurrence , 145
RFA. See Radiofrequency ablation (RFA)
Roy-Chourhury, S. , 2
S
Sedation/anesthesia, renal ablation , 141
Soft tissue tumors, primary bone ablation
chondroblastomas , 179
osteoblastomas , 178–179
radiofrequency ablation , 179–180
Spine, D.A. , 43, 46, 48
Splanchnic neurolysis , 39
Systemic lupus erythromatosis, RFA , 150–151
T
TACE See Transarterial chemoembolization
(TACE)
Targeted drug delivery , 35
Thermal ablation
de fi nition , 5
osteoid osteoma (OO) , 176–177
Thermal ablation devices
chemical ablation , 37–40
cryoablation system
advantages , 16–17
components , 15–16
cost , 16
cryoprobe design , 15
de fi nition , 13
development , 18
disadvantages , 17–18
mechanism of action , 13–15
high-intensity focused ultrasound (HIFU)
ablation , 29–35
interstitial laser ablation , 35–37
microwave ablation
equipment , 22–27
https://t.me/med1917
188
Index
Thermal ablation devices (cont.)
future aspects , 28
tissue heating , 21
plasma-radiofrequency ablation electrode
( see Plasma-mediated ablation)
radiofrequency ablation (RFA)
AngioDynamics’ StarBurst
®
, 9–10
Boston Scienti fi c , 7–8
Covidien Cool-Tip , 8–9
de fi nition , 5
electrodes , 6–7
generators , 7
principles , 5–6
Thermal effect, HIFU ablation , 30–31
Thoracic ablation
alternative therapies , 107, 109
anatomy , 100
clinical features , 97–98
complications , 109
contraindications , 99–100
diagnostic evaluation
clinical , 98
imaging , 98–99
laboratory , 98
equipment , 101–102
follow-up and postprocedure medications
atelectasis evolution , 111
complete response appearances , 106–107
immediate postprocedure appearances ,
106
incomplete response or recurrence
appearances , 107, 112
lack of enhancement , 106, 111
indications , 99
literature review , 107, 108
patient preparation , 100
precautions , 109–110
preprocedure medications , 102
procedure
access route planning , 102
deployed electrode , 104
endpoint , 105
immediate postprocedure care , 105
patient positioning , 102–103
technique , 103–105
tips , 105
Thyroid and parathyroid nodules, RFA
alternative therapies
ethanol ablation (EA) , 66–67
high-intensity focused ultrasound
(HIFU) , 67
percutaneous laser ablation (PLA) , 67
anatomy
aberrant , 57–58
normal , 56–57
clinical features , 53
complications , 68–69
contraindications
absolute , 55
relative , 56
diagnostic evaluation
clinical , 54
imaging , 54–55
laboratory , 54
equipment
electrode , 58
generator , 58
grounding pads , 58
pump , 58
follow-up and postprocedure medications ,
63–65
indications , 55
patient preparation , 56
postprocedure care , 62–63
preprocedure medications , 59
procedure
endpoint , 62
moving shot technique , 60–62
patient , 59
planning access route , 59–61
results , 65–66
Thyrotoxicosis , 68
Tissue heating , 21
Transarterial chemoembolization (TACE) , 127
Trans-isthmic approach method , 59
Transrectal devices, transducers , 33
Tsoumakidou, G. , 2
Tumor ablation , 38–39
U
Ultrasound (US) surgery, focused. See
High-intensity focused ultrasound
(HIFU) ablation
V
Vessel occlusion , 35
Von-Hippel Lindau syndrome , 141
W
Winokur, R.S. , 2
Wood, R.W. , 29
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана